HOME > COLUMN
COLUMN
-
Riding the Trend: Staffing Pharma Startups in Japan
September 7, 2018
-
How Having a Great CSR Program Can Help with Recruiting and Retaining Top Talent
August 16, 2018
-
Rare Disease Pharmaceuticals in Japan to See New Demand for Skilled Human Resources
July 20, 2018
-
5 Billion Yen Blockbuster?
June 20, 2018
-
It Is Thumbs Up for Cell Therapy in Japan
March 23, 2018
-
Unique Opportunities at Pharmaceutical Companies Treating Rare Diseases
February 23, 2018
-
When Leading Teams, Focus on the Principles, Not the Personalities
January 26, 2018
-
What to Do about the Feeling of Torschlusspanik?
October 27, 2017
-
Women! Rock the Boat and Get Promoted
September 22, 2017
-
Getting the Right Message
August 25, 2017
-
Putting on Your Pants
July 21, 2017
-
Reputable Combination
July 11, 2017
-
What Is the Best Path to Customers’ Hearts and Minds?
June 19, 2017
-
Doubling Down on Digital
May 26, 2017
-
Global Opportunities for Global Minds
April 21, 2017
-
Will Tepid Pricing Debate Only Go Full-Throttle after Golden Week Holidays?
March 30, 2017
-
Some Japanese Pharmaceutical Workers May Slowly Be Working Themselves to Death
March 17, 2017
-
The Best Recruiters Are Just a Little Paranoid
February 17, 2017
-
5 Killer Questions for HR to Ask Recruiters
January 20, 2017
-
What Pharma Can Learn from the Airline Industry
December 16, 2016
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
